<DOC>
	<DOCNO>NCT01047215</DOCNO>
	<brief_summary>The goal research investigate heart rate change schizophrenic bipolar patient medication aripiprazole quetiapine . In mean time , hop investigate interrelationship medicine dosage heart rate change , order acquire best relationship effectiveness well safety acceptable heart rate change clinical suggestion .</brief_summary>
	<brief_title>Heart Rate Changes Schizophrenic Bipolar Patients Under Medication Aripiprazole Quetiapine</brief_title>
	<detailed_description>Primary Goal : The goal research investigate heart rate change schizophrenic bipolar patient medication aripiprazole quetiapine . As know , clozapine , antipsychotic , could cause fatal cardiac arrhythmia ; previous report show fatal rate 0.7 % , spite high , reflect heart rate change decrease . Therefore , many research begin focus relationship heart rate change . Quetiapine , atypical antipsychotic , FDA approve 1997 , Department Health ( DOH ) Taiwan also approve schizophrenia effectiveness negative disorder , low extrapyramidal syndrome , low side-effects muscle catatonia sluggishness . The side-effects quetiapine lethargy , nausea ( occur rate 9 % -44 % ) , insomnia ( 12 % ) , postural hypotension ( 4 % -7 % ) , constipation ( 8-10 % ) , thirsty ( 9 % -44 % ) , weight gain ( 5-23 % ) liver enzyme ( GGT、AST、ALT ) increase ( 6 % ) . Aripiprazole , FDA approve 2002 , DOH Taiwan also approve schizophrenia effective remittance positive disorder , also effective negative disorder cognitive function regression . Besides , aripiprazole combine lithium valproic acid control onset manic mixure bipolar patient . The side-effects aripiprazole , low extrapyramidal syndrome , significant weight gain blood sugar level , surge prolactin level low menstrual cycle abnormal , gynecomastia sexual dysfunction . Other side-effects postural hypotension ( 0.6 % -4 % ) , headache ( 12 % -27 % ) , lethargy ( 8 % -18 % ) , insomnia ( 5 % -26.3 % ) , constipation ( 5-11 % ) . Both quetiapine aripiprazole atypical antipsychotic , serious side-effects few typical antipsychotic , however , sensitive patient still side-effects limb-stiffness akathisia ( quetiapine 4 % -12 % , aripiprazole 2 % -27.3 % ) . In retrospect research , quetiapine increase opportunity cardio- sudden death pas 0.3 % -1 % age 30-74 adult . On hand , aripiprazole ( 0.1 % -1 % ) show prolong QT wave consider danger factor fatal arrhythmia . Despite danger , serious side-effects rare , aripiprazole quetiapine widely use clinical . This study hope study whether quetiapine aripiprazole occur heart rate change similar clozapine , use heart rate change approach find possibility cause arrhythmia fatal 2 medicine . Secondary goal : 1 . Further investigate relationship drug dosage heart rate change , order acquire best relationship effectiveness well safety acceptable heart rate change clinical suggestion . 2 . The subject study schizophrenic bipolar patient , use quetiapine aripiprazole , also stratify gender , age influence heart rate change .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>1 . Age 20 50 , gender . 2 . Psychiatry doctor diagnose meet DSMIVTR criterion schizophrenia bipolar patient use antipsychotic . 3 . Psychiatry doctor first diagnose meet DSMIVTR criterion schizophrenia bipolar patient without use antipsychotic . 4 . Participants understand goal experiment willing cooperate evaluate heart rate change measurement . Participants need understand procedure study . 5 . Participants voluntarily join interview , approximately 3045min . 6 . Clinical review patient 's condition need use quetiapine aripiprazole . Control group 1 . Age 20 50 , gender . 2 . Psychiatry doctor diagnose exclude DSMIVTR schizophrenia bipolar patient . 3 . Participants understand goal experiment willing cooperate evaluate heart rate change measurement . Participants need understand procedure study . 4 . Participants voluntarily join interview , approximately 3045min . Experimential Group : 1 . Participants fail understand goal experiment unwilling cooperate evaluate heart rate change measurement . 2 . Participant another major mental disease inclusion criterion . 3 . Participants cardiovascular disease , diabetes , hepatic cirrhosis , kidney disease , material abuser ( smoke exclude ) longtermeffective psychotic user . 4 . Participant combination disease , could seriously influence diagnosis . 5 . Psychopathy psychosis categorize define group . 6 . Clinical review patient 's condition need switch medicine . 7 . Clinical review patient 's condition need quite experiment record reason . 8 . Participants decide quite experiment without condition . Control group 1 . Participants fail understand goal experiment unwilling cooperate evaluate heart rate change measurement . 2 . Participants cardiovascular disease , diabetes , hepatic cirrhosis , kidney disease , material abuser ( smoke exclude ) longtermeffective psychotic user . 3 . Participants decide quite experiment without condition .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>schizophrenia</keyword>
	<keyword>bipolar</keyword>
	<keyword>aripiprazole</keyword>
	<keyword>quetiapine</keyword>
</DOC>